Broomfield medical-device company launches early-stage study
BROOMFIELD — Colibri Heart Valve LLC, a medical device company, has enrolled the first two patients in its clinical early feasibility study for one of its medical devices.
The Broomfield-based company is testing its ready-for-use balloon-expandable transcatheter aortic-valve implantation, or TAVI, system. The system contains a replacement aortic heart valve that is pre-mounted and pre-crimped on a balloon delivery catheter, that is already sterilized and ready to implant direct from the package. This product is the second generation from the system and can address a wider range of patients.
The two patients in the early feasibility study were successfully implanted with the TAVI system. The company plans to enroll up to 10 patients and will have 30-day follow-up data.
March 31 Mullen Group Ltd
* Mullen Group Ltd. announces the acquisition of Envolve Energy Services Corp. A well disposal business situated in the montney resource play
* Mullen Group Ltd - expect Envolve 1 will generate annual revenue of $8.0 million, a roce of about 25.0 percent and be immediately accretive to Mullen Group
* Mullen Group Ltd - will use balance sheet to fund additional facilities, built under new build strategy Source text for Eikon: Further company coverage: